# Novel Biomarkers Related Xuebijing Injection Improves Sepsis

> **NCT06920420** · — · NOT_YET_RECRUITING · sponsor: **Southeast University, China** · enrollment: 30 (estimated)

## Conditions studied

- Sepsis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06920420
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-30
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06920420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06920420, "Novel Biomarkers Related Xuebijing Injection Improves Sepsis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06920420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*